USANA Health Sciences ROA 2012-2026 | USNA

Current and historical return on assets (ROA) values for USANA Health Sciences (USNA) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
USANA Health Sciences ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2026-06-30 $-0.02B $0.73B -3.02%
2026-03-31 $0.01B $0.74B 1.22%
2025-12-31 $0.01B $0.74B 1.36%
2025-09-30 $0.02B $0.74B 2.16%
2025-06-30 $0.03B $0.73B 4.69%
2025-03-31 $0.03B $0.70B 4.86%
2024-12-31 $0.04B $0.67B 6.27%
2024-09-30 $0.06B $0.64B 8.58%
2024-06-30 $0.06B $0.62B 8.82%
2024-03-31 $0.06B $0.62B 10.06%
2023-12-31 $0.06B $0.61B 10.32%
2023-09-30 $0.06B $0.60B 9.80%
2023-06-30 $0.06B $0.59B 10.67%
2023-03-31 $0.07B $0.58B 11.22%
2022-12-31 $0.07B $0.57B 12.08%
2022-09-30 $0.08B $0.57B 13.42%
2022-06-30 $0.09B $0.57B 15.38%
2022-03-31 $0.11B $0.58B 18.44%
2021-12-31 $0.12B $0.58B 19.89%
2021-09-30 $0.14B $0.60B 22.70%
2021-06-30 $0.14B $0.60B 23.38%
2021-03-31 $0.13B $0.58B 22.45%
2020-12-31 $0.13B $0.55B 22.86%
2020-09-30 $0.12B $0.52B 22.49%
2020-06-30 $0.11B $0.49B 22.38%
2020-03-31 $0.10B $0.50B 20.75%
2019-12-31 $0.10B $0.52B 19.38%
2019-09-30 $0.10B $0.53B 19.23%
2019-06-30 $0.11B $0.56B 19.31%
2019-03-31 $0.12B $0.57B 21.23%
2018-12-31 $0.13B $0.57B 22.16%
2018-09-30 $0.09B $0.56B 15.72%
2018-06-30 $0.08B $0.53B 15.20%
2018-03-31 $0.07B $0.52B 13.46%
2017-12-31 $0.06B $0.50B 12.36%
2017-09-30 $0.09B $0.49B 18.38%
2017-06-30 $0.10B $0.48B 20.08%
2017-03-31 $0.10B $0.45B 22.04%
2016-12-31 $0.10B $0.44B 22.77%
2016-09-30 $0.10B $0.43B 23.87%
2016-06-30 $0.10B $0.43B 23.00%
2016-03-31 $0.10B $0.43B 22.78%
2015-12-31 $0.10B $0.41B 23.09%
2015-09-30 $0.09B $0.39B 23.38%
2015-06-30 $0.09B $0.36B 23.42%
2015-03-31 $0.08B $0.35B 22.60%
2014-12-31 $0.08B $0.35B 21.81%
2014-09-30 $0.08B $0.35B 21.26%
2014-06-30 $0.07B $0.36B 20.49%
2014-03-31 $0.08B $0.34B 22.79%
2013-12-31 $0.08B $0.32B 24.94%
2013-09-30 $0.08B $0.29B 26.42%
2013-06-30 $0.08B $0.28B 27.77%
2013-03-31 $0.07B $0.27B 26.14%
2012-12-31 $0.07B $0.27B 24.74%
2012-09-30 $0.06B $0.26B 23.37%
2012-06-30 $0.06B $0.25B 22.42%
2012-03-31 $0.05B $0.24B 22.46%
2011-12-31 $0.05B $0.22B 22.57%
2011-09-30 $0.05B $0.22B 22.82%
2011-06-30 $0.05B $0.21B 24.04%
2011-03-31 $0.05B $0.19B 24.42%
2010-12-31 $0.05B $0.17B 26.47%
2010-09-30 $0.04B $0.15B 29.28%
2010-06-30 $0.04B $0.13B 30.00%
2010-03-31 $0.04B $0.12B 29.84%
2009-12-31 $0.03B $0.12B 28.10%
2009-09-30 $0.03B $0.12B 23.14%
2009-06-30 $0.03B $0.12B 23.14%
2009-03-31 $0.03B $0.12B 24.17%
2008-12-31 $0.03B $0.12B 24.27%
2008-09-30 $0.04B $0.12B 31.03%
2008-06-30 $0.04B $0.11B 35.06%
2008-03-31 $0.04B $0.11B 37.65%
2007-12-31 $0.05B $0.11B 43.06%
2007-09-30 $0.04B $0.10B 43.03%
2007-06-30 $0.04B $0.10B 43.65%
2007-03-31 $0.04B $0.09B 45.65%
2006-12-31 $0.04B $0.09B 46.38%
2006-09-30 $0.04B $0.08B 50.16%
2006-06-30 $0.04B $0.08B 48.93%
2006-03-31 $0.04B $0.09B 47.20%
2005-12-31 $0.04B $0.08B 46.43%
2005-09-30 $0.04B $0.08B 45.51%
2005-06-30 $0.04B $0.08B 45.86%
2005-03-31 $0.03B $0.07B 44.44%
2004-12-31 $0.03B $0.07B 43.32%
2004-09-30 $0.03B $0.07B 41.48%
2004-06-30 $0.03B $0.06B 41.94%
2004-03-31 $0.02B $0.06B 39.83%
2003-12-31 $0.02B $0.05B 41.18%
2003-09-30 $0.02B $0.05B 38.20%
2003-06-30 $0.01B $0.04B 32.10%
2003-03-31 $0.01B $0.04B 29.33%
2002-12-31 $0.01B $0.04B 21.62%
2002-09-30 $0.01B $0.04B 16.67%
2002-06-30 $0.01B $0.04B 13.79%
2002-03-31 $0.00B $0.04B 8.16%
2001-12-31 $0.00B $0.04B 5.52%
2001-09-30 $0.00B $0.04B 5.52%
2001-06-30 $0.00B $0.04B 2.72%
2001-03-31 $0.00B $0.04B 2.70%
2000-12-31 $0.00B $0.04B 5.23%
2000-09-30 $0.00B $0.04B 7.74%
2000-06-30 $0.00B $0.04B 5.19%
2000-03-31 $0.00B $0.04B 10.32%
1999-12-31 $0.01B $0.04B 12.74%
1999-09-30 $0.01B $0.04B 15.00%
1999-06-30 $0.01B $0.04B 25.32%
1999-03-31 $0.01B $0.04B 26.32%
1998-12-31 $0.01B $0.04B 27.97%
1998-09-30 $0.01B $0.03B 27.91%
1998-06-30 $0.01B $0.03B 27.59%
1998-03-31 $0.01B $0.03B 31.07%
1997-12-31 $0.01B $0.02B 30.77%
1997-09-30 $0.01B $0.02B 27.91%
1997-06-30 $0.01B $0.02B 25.00%
1997-03-31 $0.00B $0.02B 21.62%
1996-12-31 $0.00B $0.02B 24.62%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.275B $0.925B
USANA Health Sciences Inc. develops and manufactures high-quality nutritional, personal care and weight management products. The company's three primary product lines consist of nutritional, personal care and weight management products. The company's products are distributed primarily through a network marketing system.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $68.396B 22.59
Takeda Pharmaceutical (TAK) Japan $59.919B 11.13
UCB SA (UCBJY) Belgium $45.739B 0.00
Otsuka Holdings, - (OTSKY) Japan $39.680B 14.84
BeOne Medicines - (ONC) Switzerland $38.041B 61.00
Sandoz Group AG (SDZNY) Switzerland $35.464B 0.00
Daiichi Sankyo, - (DSNKY) Japan $34.072B 21.27
Zoetis (ZTS) United States $30.343B 11.16
Astellas Pharma (ALPMY) Japan $26.892B 8.90
United Therapeutics (UTHR) United States $21.460B 17.90
Merck (MKKGY) Germany $19.487B 15.54
Shionogi (SGIOY) Japan $15.947B 9.37
IPSEN (IPSEY) France $15.395B 0.00
Neurocrine Biosciences (NBIX) United States $15.249B 20.72
Summit Therapeutics (SMMT) United States $13.881B 0.00
Orion OYJ (ORINY) Finland $12.984B 18.93
Madrigal Pharmaceuticals (MDGL) United States $12.089B 0.00
Corcept Therapeutics (CORT) United States $11.979B 263.86
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.965B 15.26
Crinetics Pharmaceuticals (CRNX) United States $9.013B 0.00
Eisai (ESAIY) $8.924B 0.00
Ionis Pharmaceuticals (IONS) United States $7.852B 0.00
Ono Pharmaceutical (OPHLF) Japan $7.049B 13.27
Stevanato Group S.p.A (STVN) Italy $6.523B 32.64
Centessa Pharmaceuticals (CNTA) United Kingdom $6.267B 0.00
Oruka Therapeutics (ORKA) United States $6.105B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $5.317B 19.36
Grifols, S.A (GRFS) Spain $5.009B 0.00
Definium Therapeutics (DFTX) United States $4.947B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.923B 0.00
Relay Therapeutics (RLAY) United States $4.157B 0.00
Indivior Pharmaceuticals (INDV) United States $4.039B 9.38
Enliven Therapeutics (ELVN) United States $3.910B 0.00
Catalyst Pharmaceuticals (CPRX) United States $3.855B 11.93
Amylyx Pharmaceuticals (AMLX) United States $3.694B 0.00
Dyne Therapeutics (DYN) United States $3.343B 0.00
Hypermarcas (HYPMY) Brazil $3.203B 9.10
Soleno Therapeutics (SLNO) United States $2.717B 228.83
NewAmsterdam Pharma (NAMS) Netherlands $2.529B 0.00
Guardian Pharmacy Services (GRDN) United States $2.390B 45.28
Nektar Therapeutics (NKTR) United States $2.275B 0.00
Ocular Therapeutix (OCUL) United States $2.238B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.146B 15.81
Avadel Pharmaceuticals (AVDL) Ireland $2.113B 0.00
BioCryst Pharmaceuticals (BCRX) United States $2.085B 5.63
Xencor (XNCR) United States $1.766B 0.00
KARDIGAN INC (KARD) United States $1.735B 0.00
Xeris Biopharma Holdings (XERS) United States $1.366B 107.00
Harrow (HROW) United States $1.269B 0.00
Seaport Therapeutics (SPTX) United States $1.229B 0.00
Aktis Oncology (AKTS) United States $1.204B 0.00
Cronos Group (CRON) Canada $1.179B 29.09
Bioventus (BVS) United States $1.093B 17.10
Savara (SVRA) United States $1.081B 0.00
KalVista Pharmaceuticals (KALV) United States $0.993B 0.00
Cybin (HELP) Canada $0.992B 0.00
Theravance Biopharma (TBPH) United States $0.885B 0.00
Avalo Therapeutics (AVTX) United States $0.862B 0.00
Ardelyx (ARDX) United States $0.847B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.821B 11.32
Esperion Therapeutics (ESPR) United States $0.819B 0.00
Aclaris Therapeutics (ACRS) United States $0.773B 0.00
Achieve Life Sciences (ACHV) Canada $0.753B 0.00
4D Molecular Therapeutics (FDMT) United States $0.753B 0.00
Silence Therapeutics (SLN) United Kingdom $0.750B 0.00
Apnimed (APMD) $0.711B 0.00
Collegium Pharmaceutical (COLL) United States $0.711B 3.13
Zevra Therapeutics (ZVRA) United States $0.692B 7.37
Ironwood Pharmaceuticals (IRWD) United States $0.671B 5.21
OmniAb (OABI) United States $0.630B 0.00
Altimmune (ALT) United States $0.628B 0.00
Aquestive Therapeutics (AQST) United States $0.604B 0.00
Evotec AG (EVO) Germany $0.580B 0.00
ProKidney (PROK) United States $0.526B 0.00
Indaptus Therapeutics (INDP) United States $0.485B 0.00
Relmada Therapeutics (RLMD) United States $0.474B 0.00
ARS Pharmaceuticals (SPRY) United States $0.423B 0.00
Larimar Therapeutics (LRMR) United States $0.406B 0.00
Prelude Therapeutics (PRLD) United States $0.361B 0.00
Century Therapeutics (IPSC) United States $0.359B 0.00
Lexeo Therapeutics (LXEO) United States $0.339B 0.00
Inhibikase Therapeutics (IKT) United States $0.322B 0.00
Avita Medical (RCEL) United States $0.314B 0.00
Pyxis Oncology (PYXS) United States $0.278B 0.00
Elite Pharmaceuticals (ELTP) United States $0.268B 12.44
Lyell Immunopharma (LYEL) United States $0.267B 0.00
Akebia Therapeutics (AKBA) United States $0.250B 0.00
Galectin Therapeutics (GALT) United States $0.246B 0.00
Nature's Sunshine Products (NATR) United States $0.230B 11.17
AleAnna (ANNA) United States $0.226B 17.84
Protara Therapeutics (TARA) United States $0.222B 0.00
Cardiol Therapeutics (CRDL) Canada $0.215B 0.00
Siga Technologies (SIGA) United States $0.214B 0.00
Journey Medical (DERM) United States $0.208B 0.00
Profound Medical (PROF) Canada $0.208B 0.00
Korro Bio (KRRO) United States $0.207B 0.00
Surrozen (SRZN) United States $0.206B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.199B 0.00
Organogenesis (ORGO) United States $0.188B 0.00
Minerva Neurosciences (NERV) United States $0.183B 0.00
MediWound (MDWD) Israel $0.173B 0.00
Atrium Therapeutics (RNA) United States $0.173B 0.00
NRx Pharmaceuticals (NRXP) United States $0.147B 0.00
Innate Pharma SA (IPHYF) France $0.138B 0.00
Unicycive Therapeutics (UNCY) United States $0.131B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.129B 0.00
VAXART, INC (VXRT) United States $0.117B 3.00
Assertio Holdings (ASRT) United States $0.116B 0.00
Rafael Holdings (RFL) United States $0.111B 0.00
Vivani Medical (VANI) United States $0.111B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.103B 0.00
Cassava Sciences (SAVA) United States $0.101B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.099B 0.00
PolyPid (PYPD) Israel $0.098B 0.00
HST Global (HSTC) United States $0.092B 0.00
ElectroCore (ECOR) United States $0.091B 0.00
Fractyl Health (GUTS) United States $0.090B 0.00
Nutriband (NTRB) United States $0.083B 0.00
Aldeyra Therapeutics (ALDX) United States $0.083B 0.00
Telomir Pharmaceuticals (TELO) United States $0.080B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.079B 0.00
Acrivon Therapeutics (ACRV) United States $0.078B 0.00
Gain Therapeutics (GANX) United States $0.075B 0.00
PMV Pharmaceuticals (PMVP) United States $0.073B 0.00
Champions Oncology (CSBR) United States $0.066B 0.00
Talphera (TLPH) United States $0.062B 0.00
Nuo Therapeutics (AURX) $0.061B 0.00
Heron Therapeutics (HRTX) United States $0.060B 0.00
Dominari Holdings (DOMH) United States $0.053B 0.00
Veraxa Biotech AG (VRXA) United States $0.048B 0.00
SCYNEXIS (SCYX) United States $0.044B 0.00
Incannex Healthcare (IXHL) Australia $0.041B 0.00
FibroGen (FGEN) United States $0.039B 0.00
Lite Strategy (LITS) United States $0.037B 0.00
Mural Oncology (MURA) Ireland $0.035B 0.00
Karyopharm Therapeutics (KPTI) United States $0.035B 0.00
Context Therapeutics (CNTX) United States $0.033B 0.00
Optimi Health (OPTH) Canada $0.029B 0.00
Cosmos Health (COSM) United States $0.028B 0.00
TransCode Therapeutics (RNAZ) United States $0.027B 0.00
Plus Therapeutics (PSTV) United States $0.027B 0.00
TherapeuticsMD (TXMD) United States $0.025B 0.00
Universe Pharmaceuticals INC (UPC) China $0.022B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.020B 0.00
VYNE Therapeutics (VYNE) United States $0.019B 0.00
Lipocine (LPCN) United States $0.018B 0.00
Klotho Neurosciences (KLTO) United States $0.016B 0.00
Mannatech (MTEX) United States $0.016B 0.00
Enlivex (ENLV) Israel $0.015B 0.00
Citius Pharmaceuticals (CTXR) United States $0.015B 0.00
BioVie (BIVI) United States $0.015B 0.00
Iterum Therapeutics (ITRM) Ireland $0.015B 0.00
Vyome Holdings (HIND) United States $0.014B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.014B 0.00
Scienture Holdings (SCNX) United States $0.014B 0.00
Tempest Therapeutics (TPST) United States $0.012B 0.00
Natural Alternatives (NAII) United States $0.012B 0.00
BioLineRx (BLRX) Israel $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.012B 0.00
CASI Pharmaceuticals (CASI) China $0.010B 0.00
Xenetic Biosciences (XBIO) United States $0.010B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Wellgistics Health (WGRX) United States $0.009B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Inotiv (NOTV) United States $0.008B 0.00
Biomerica (BMRA) United States $0.007B 0.00
Curanex Pharmaceuticals Inc (CURX) United States $0.007B 0.00
Ernexa Therapeutics (ERNA) United States $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Heatwurx (PCSA) United States $0.005B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.005B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.005B 0.00
Liminatus Pharma (LIMN) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
Niki BioSolutions (NIKI) United Kingdom $0.004B 0.00
Nuvilex (PMCB) United States $0.004B 0.00
Addex Therapeutics (ADXN) Switzerland $0.004B 0.00
Galmed Pharmaceuticals (EOCN) Israel $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Jupiter Neurosciences (JUNS) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Vivos Therapeutics (VVOS) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Jaguar Animal Health (JAGX) United States $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Clearmind Medicine (CMND) Canada $0.001B 0.00
PainReform (PRFX) Israel $0.001B 0.00
CDT Equity (CDT) United States $0.000B 0.00
Emisphere Technologies (EMIS) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00